The Department’s physicians continue to advance a wide range of treatment options for patients with prostate cancer. Our Precision Urology™ approach—which integrates multiple variables and imaging data for superior diagnosis and treatment decision-making—ensures our patients receive highly personalized and comprehensive care.

 Our prostate cancer surgeons have performed more than 9,000 robotic prostatectomies and also pioneered procedures—including a completely athermal technique (no use of cautery or heat energy) during robotic prostatectomy, and the total reconstruction technique. In the total reconstruction technique, the support structures of the urinary mechanism are restored following prostate removal, providing patients with a faster continence recovery.

We also remain at the forefront of diagnostic imaging for prostate cancer, specifically ultrasound guided fusion biopsy.  Currently we are one of two test centers worldwide collaborating with Philips Health Care to further refine fusion biopsy technology and develop applications for guided focal therapies.

Our Robotic Bladder Cancer Program is led by Peter Wiklund, MD, PhD, whose extensive experience with robot-assisted surgeries includes cystectomy with totally intracorporeal neobladder procedures. The bladder cancer team has performed more than 3,000 robotic operations and carries additional experience in advanced pelvic oncological surgery, in which the tumor is growing on several pelvic organs (bladder, prostate, colorectal, ovarian, uterine). 

Our Comprehensive Kidney Cancer and Robotic Kidney Cancer Surgery Programs  are led by Ketan Badani, MD, Vice Chair of Urology and Robotic Operations for the Mount Sinai Health System. A national leader in the research and treatment of urologic cancers, Dr. Badani performs robotic partial nephrectomy for complex kidney tumors. His technique, the F.A.S.T. procedure (First Assistant Sparing Technique), has been published and taught around the world to treat patients with renal tumors.

The Comprehensive Kidney Cancer Program is a multidisciplinary and collaborative effort, and members of the Department often partner with those in nephrology, interventional radiology, and medical oncology.  When appropriate, we also use ablation or place patients on an active surveillance protocol. 

The Department of Urology offers the latest, minimally invasive technologies and treatments for benign prostatic hyperplasia, including holmium laser enucleation of the prostate, Greenlight ™ Laser PVP treatment, and bipolar cautery vaporization. The UroLift System™, a new minimally invasive device designed to treat lower urinary tract symptoms, is also available at The Mount Sinai Hospital.

The Department of Urology provides comprehensive resources for the evaluation and treatment of urinary incontinence, neuro-urological problems caused by diseases such as multiple sclerosis and diabetes, and pelvic pain syndrome. Our specialists are also among the few in the country with advanced training in urethral reconstruction.

The Mount Sinai Sexual Health Program uses the most advanced techniques available to evaluate the underlying hormonal, neurogenic, vascular, and psychogenic causes of sexual dysfunction. Treatment options include oral medications, hormone replacement therapy, counseling, intraurethral medication, injection therapy, external vacuum therapy, penile prosthesis, and reconstructive surgery. For patients facing infertility, our personalized treatment options include in vitro fertilization techniques, medication, and microsurgical repairs, all of which have high success rates.

The Kidney Stone Center at Mount Sinai offers a multidisciplinary approach to manage and treat kidney stones. Our integrated team of urologists, nephrologists, and other specialists provide a wide range of noninvasive and minimally invasive procedures to remove small and large stones. Led by Mantu Gupta, MD, who has pioneered many of the methods and strategies currently used to treat kidney stones, our Center uses the latest technological advances, including state-of-the-art lasers.    

The Department excels in treating urologic problems in newborns, infants, children, and adolescents. The Division of Pediatric Urology led by Jeffrey Stock, MD offers the latest minimally invasive treatments, including robot-assisted surgery for major reconstructive procedures.

The Department regularly sees patients from around the region for advanced diagnostic and treatment procedures. Equipped with one of the most extensive robotics programs in the world, our surgeons handle a broad range of complex and challenging cases. We also work as members of interdisciplinary teams with our colleagues throughout the Mount Sinai Health System to achieve the best outcomes for our patients. Our recent successes include the effective management of a renal cell carcinoma with atrial tumor thrombus during pregnancy, the first reported use of robotic surgery for treating chyluria, and a renal auto-transplantation for repair of a chronic ureteral stricture.